Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Copan Expands US Manufacturing Operations with Multimillion Dollar Investment

By LabMedica International staff writers
Posted on 03 Sep 2009
Copan Diagnostics, Inc. More...
(Murrieta, CA, USA) is undertaking a new multimillion US dollar investment project to bring plastic transfer pipette and additional medical device manufacturing operations to its California, USA facility.

Plastic transfer pipettes are essential products widely used by hospital and other laboratories for transferring liquids and clinical samples during diagnostics testing or analytical research. As many as 500 million pipettes are used in the United States annually. Copan developed a customized blow molding equipment that maximizes productivity through a fully automated system for separating the molded product from waste material, which is then 100% recycled.

A 1208 m2 building adjacent to its current facility was purchased by Copan to house new plastic blow molding equipment that is used to manufacture transfer pipettes. The new building allows the transfer of some activities from its current location, thus allowing more space for Copan to expand medical device manufacturing operations for the company's microbiology specimen collection and transport line.

The project is an integral part of Copan's plan to support future demand. Norman Sharples, executive vice president at Copan Diagnostics, said, "in today's market, companies must examine opportunities to bring further efficiencies to their operations to remain competitive, which is what we are doing with this endeavor."

Copan Diagnostics manufactures collection and transport systems and offers a complete range of microbial sampling products for traditional culture analysis and molecular diagnostic assays. The company also produces flocked swabs, universal transport medium, the ESwab and other laboratory consumables. The Walk-Away Specimen Processor (WASP), a system for automatic planting and streaking of microbiology samples, is another Copan product.

Related Links:
Copan Diagnostics, Inc.




Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.